NCT04912193View on ClinicalTrials.gov

Antithrombin III and Post-liver Transplantation Acute Kidney Injury

CompletedOBSERVATIONAL
Enrollment

2,395

Participants

Timeline

Start Date

January 4, 2010

Primary Completion Date

January 31, 2019

Study Completion Date

December 31, 2019

Conditions
Liver Transplantation and Antithrombin
Interventions
DRUG

Antithrombin III

In liver transplant recipients with baseline antithrombin III levels lower than 50%, exogenous Antithrombin III was administrated during the anhepatic phase of the liver transplant surgery.

Trial Locations (1)

05507

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER